Nelson Advisors joins SoftBank Vision Fund, J.P. Morgan, IQVIA, Siemens Healthineers, Blackstone, Mayo Clinic, Cedars Sinai executives at the Capital Xchange Forum 2026
Nelson Advisors joins SoftBank Vision Fund, J.P. Morgan, IQVIA, Siemens Healthineers, Blackstone, Mayo Clinic, Cedars Sinai executives at the Capital Xchange Forum 2026.
Day 1: Capital Xchange Forum, Global Health Exhibition 2026 > Saudi Healthcare Deployment, Market Entry, FDI & Partnerships PANEL: HealthTech Funding and M&A, From Growth Capital to Strategic Exits A practical discussion on healthtech funding and M&A activity in 2026 versus 2025, exploring how investors are backing fewer but stronger companies, how AI and tech-enabled care are reshaping value creation, and what founders, operators and investors need to build towards strategic exits. DISCUSSION POINTS • How have funding, valuations and diligence changed since 2025? • Which AI and tech-enabled care models are attracting durable capital? • What milestones make a company strategically ready for acquisition or exit? MODERATOR Dr. Rana Lonnen: Healthcare and Life Sciences Investor and Advisor, Wyss Center for Bio and Neuroengineering SPEAKERS Lloyd Price: Partner and Co-Founder, Nelson Advisors Dr. Ibrahim Alnajashi: Chairman, Najashi Holding Mansa Shroff, MBA: Vice President, Healthcare, The CFI Group Sou Miyake, PhD: Head of Venture Investment, Corundum Systems Biology Dr. Elena Lovo: Executive Director and Head of Life Sciences EMEA, Innovation Economy, J.P. Morgan |
Day 2: Capital Xchange Forum, Global Health Exhibition 2026 > Allocators, LPs, GPs & Capital Formation in Healthcare PANEL: Innovation in Action, Where Are Investors Putting Their Money? An investor-led discussion on identifying emerging technologies and assessing opportunities before they reach the mainstream market. DISCUSSION POINTS • Which technologies and care models are moving into investor focus? • How do investors distinguish durable opportunities from short-lived hype? • What evidence triggers conviction before a category becomes mainstream? MODERATOR Feras Mahdi: Partner, Healthcare and Life Sciences, Simon-Kucher SPEAKERS Dr. Ghida Harfouche: Partner, TVM Capital Healthcare Antony Kalindjian, PhD: Investment Vice President, Life Sciences and HealthTech, SoftBank Vision Fund Lloyd Price: Partner and Co-Founder, Nelson Advisors Dr. Elena Lovo: Executive Director and Head of Life Sciences EMEA, Innovation Economy, J.P. Morgan Mina Bekheet: Founder and Chief Executive Officer, Panacea |
Nelson Advisors > European Healthcare Technology Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV. www.nelsonadvisors.co.uk
Healthcare.Digital is the Google News approved HealthTech and MedTech Thought Leadership platform for Nelson Advisors, positioning them as a specialised authority on European Healthcare Technology M&A and strategic corporate development. https://www.healthcare.digital
Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb
Healthcare.Digital serves as a research platform for Nelson Advisors’ perspectives on deals, valuations and structural shifts reshaping Global Digital Health, MedTech, Healthcare AI and Health IT. https://www.healthcare.digital
Nelson Advisors is one of Europe's leading mergers and acquisitions advisory firms, exclusively dedicated to the dynamic and rapidly evolving healthcare technology sector. With a deep understanding of market dynamics and technological advancements, they empower innovative HealthTech companies and strategic investors to navigate complex transactions and achieve their growth ambitions. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech#MedTech#DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #FemTech#ConsumerHealth #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #Canada#Commonwealth#CorporateDivestitures #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #Genomics
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ Events in 2026
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
HealthInvestor Healthcare Summit > September 2026, London, UK
World Health Summit 2026 > October 2026, Berlin, Germany
HLTH USA 2026 > October 2026, USA
Global Health Exhibition 2026 > October 2026, Riyadh, Saudi Arabia
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Leaders in Health Summit 2026 > November 2026, London, UK
Venture Capital World Summit > December 2026, Toronto, Canada
Meet Nelson Advisors @ Events in 2027
Digital Health Rewired > March 2027 > Birmingham, UK
Barclays Health Elevate > March 2027, London, UK
NHS ConfedExpo > June 2027 > Manchester, UK
HLTH Europe > June 2027, Amsterdam, Netherlands
Comments